GB974625A - Injectable pharmaceutical emulsion vehicles - Google Patents
Injectable pharmaceutical emulsion vehiclesInfo
- Publication number
- GB974625A GB974625A GB29950/61A GB2995061A GB974625A GB 974625 A GB974625 A GB 974625A GB 29950/61 A GB29950/61 A GB 29950/61A GB 2995061 A GB2995061 A GB 2995061A GB 974625 A GB974625 A GB 974625A
- Authority
- GB
- United Kingdom
- Prior art keywords
- viruses
- influenza
- derived
- pollens
- venoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008251 pharmaceutical emulsion Substances 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 2
- 239000013566 allergen Substances 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 239000000839 emulsion Substances 0.000 abstract 2
- 239000000284 extract Substances 0.000 abstract 2
- 244000036975 Ambrosia artemisiifolia Species 0.000 abstract 1
- 235000003129 Ambrosia artemisiifolia var elatior Nutrition 0.000 abstract 1
- 241000239290 Araneae Species 0.000 abstract 1
- 241000193738 Bacillus anthracis Species 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000588832 Bordetella pertussis Species 0.000 abstract 1
- 241000712083 Canine morbillivirus Species 0.000 abstract 1
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 206010008631 Cholera Diseases 0.000 abstract 1
- 241000193155 Clostridium botulinum Species 0.000 abstract 1
- 241000193468 Clostridium perfringens Species 0.000 abstract 1
- 241000193449 Clostridium tetani Species 0.000 abstract 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 abstract 1
- 208000031912 Endemic Flea-Borne Typhus Diseases 0.000 abstract 1
- 206010014979 Epidemic typhus Diseases 0.000 abstract 1
- 241000282324 Felis Species 0.000 abstract 1
- 208000000666 Fowlpox Diseases 0.000 abstract 1
- 241000238631 Hexapoda Species 0.000 abstract 1
- 241000270322 Lepidosauria Species 0.000 abstract 1
- 241000589902 Leptospira Species 0.000 abstract 1
- 201000005505 Measles Diseases 0.000 abstract 1
- 208000005647 Mumps Diseases 0.000 abstract 1
- 206010028282 Murine typhus Diseases 0.000 abstract 1
- 208000010359 Newcastle Disease Diseases 0.000 abstract 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 abstract 1
- 241000606856 Pasteurella multocida Species 0.000 abstract 1
- 208000008939 Pneumonic Pasteurellosis Diseases 0.000 abstract 1
- 208000000474 Poliomyelitis Diseases 0.000 abstract 1
- 206010037742 Rabies Diseases 0.000 abstract 1
- 241000606701 Rickettsia Species 0.000 abstract 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 abstract 1
- 241000577483 Salmonella enterica subsp. enterica serovar Paratyphi B Species 0.000 abstract 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 abstract 1
- 239000004147 Sorbitan trioleate Substances 0.000 abstract 1
- 241000607626 Vibrio cholerae Species 0.000 abstract 1
- 241000607479 Yersinia pestis Species 0.000 abstract 1
- 239000011149 active material Substances 0.000 abstract 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 abstract 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 abstract 1
- 235000003484 annual ragweed Nutrition 0.000 abstract 1
- 239000008346 aqueous phase Substances 0.000 abstract 1
- 235000006263 bur ragweed Nutrition 0.000 abstract 1
- 235000003488 common ragweed Nutrition 0.000 abstract 1
- UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000000428 dust Substances 0.000 abstract 1
- 201000002491 encephalomyelitis Diseases 0.000 abstract 1
- 201000005901 endemic typhus Diseases 0.000 abstract 1
- 208000028104 epidemic louse-borne typhus Diseases 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 208000010805 mumps infectious disease Diseases 0.000 abstract 1
- 239000002574 poison Substances 0.000 abstract 1
- 231100000614 poison Toxicity 0.000 abstract 1
- 235000009736 ragweed Nutrition 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 239000003998 snake venom Substances 0.000 abstract 1
- 229960000391 sorbitan trioleate Drugs 0.000 abstract 1
- 235000019337 sorbitan trioleate Nutrition 0.000 abstract 1
- 239000002708 spider venom Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract 1
- 239000008158 vegetable oil Substances 0.000 abstract 1
- 239000003981 vehicle Substances 0.000 abstract 1
- 239000002435 venom Substances 0.000 abstract 1
- 231100000611 venom Toxicity 0.000 abstract 1
- 210000001048 venom Anatomy 0.000 abstract 1
- 239000007762 w/o emulsion Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5393160A | 1960-09-06 | 1960-09-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB974625A true GB974625A (en) | 1964-11-11 |
Family
ID=21987534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB29950/61A Expired GB974625A (en) | 1960-09-06 | 1961-08-18 | Injectable pharmaceutical emulsion vehicles |
Country Status (4)
| Country | Link |
|---|---|
| CH (1) | CH413237A (enrdf_load_html_response) |
| FR (1) | FR4690M (enrdf_load_html_response) |
| GB (1) | GB974625A (enrdf_load_html_response) |
| NL (1) | NL269002A (enrdf_load_html_response) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4158054A (en) | 1973-10-18 | 1979-06-12 | Duncan Flockhart & Co. Ltd. | Preparation of virus sub-unit vaccines |
| FR2443873A1 (fr) * | 1978-12-14 | 1980-07-11 | Kao Corp | Nouvelle composition emulsifiante pour la production et la stabilisation d'emulsions du type eau-dans-huile |
| GB2170708A (en) * | 1985-02-10 | 1986-08-13 | Israel State | Injectable vaccine system |
| USRE32393E (en) * | 1967-09-01 | 1987-04-07 | Kabivitrum Ab | Composition for enhancing the administration of pharmacologically active agents |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH662944A5 (it) * | 1984-10-18 | 1987-11-13 | Pier Luigi Prof Dr Luisi | Procedimento per la preparazione di biocompatibili di micelle inverse di biocompatibili e loro utilizzazione. |
| DE3446515A1 (de) * | 1984-12-20 | 1986-06-26 | Behringwerke Ag, 3550 Marburg | Oeladjuvierte vaccine und verfahren zu ihrer herstellung |
| FR2702373B1 (fr) * | 1993-03-08 | 1996-06-07 | Rhone Merieux | Emulsions vaccinales fluides eau-dans-l'huile contenant une huile métabolisable. |
| FR2702374B1 (fr) * | 1993-03-08 | 1995-04-14 | Rhone Merieux | Emulsions vaccinales fluides eau-dans-l'huile contenant une huile métabolisable. |
-
0
- NL NL269002D patent/NL269002A/xx unknown
-
1961
- 1961-08-18 GB GB29950/61A patent/GB974625A/en not_active Expired
- 1961-09-06 CH CH1032761A patent/CH413237A/de unknown
-
1963
- 1963-10-04 FR FR949656A patent/FR4690M/fr not_active Expired
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE32393E (en) * | 1967-09-01 | 1987-04-07 | Kabivitrum Ab | Composition for enhancing the administration of pharmacologically active agents |
| US4158054A (en) | 1973-10-18 | 1979-06-12 | Duncan Flockhart & Co. Ltd. | Preparation of virus sub-unit vaccines |
| FR2443873A1 (fr) * | 1978-12-14 | 1980-07-11 | Kao Corp | Nouvelle composition emulsifiante pour la production et la stabilisation d'emulsions du type eau-dans-huile |
| GB2170708A (en) * | 1985-02-10 | 1986-08-13 | Israel State | Injectable vaccine system |
Also Published As
| Publication number | Publication date |
|---|---|
| CH413237A (de) | 1966-05-15 |
| NL269002A (enrdf_load_html_response) | |
| FR4690M (enrdf_load_html_response) | 1966-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB974625A (en) | Injectable pharmaceutical emulsion vehicles | |
| DE60036952T2 (de) | Influenzavirus-impfstoffzusammensetzung zur nasalen anwendung | |
| DE3911442C2 (de) | Impfstoff-Präparation | |
| CA1147722A (en) | Immunologic adjuvant | |
| JPS6011429A (ja) | アジュバント生ワクチンの製造方法 | |
| EP0023865A2 (en) | New glycolipid compounds, process for preparation and use as immunological adjuvant | |
| Ditchfield et al. | Upper respiratory disease in Thoroughbred horses: studies of its viral etiology in the Toronto area, 1960 to 1963 | |
| DE2945788C2 (enrdf_load_html_response) | ||
| EP0028196B1 (en) | Glycolipid derivatives, their preparation and compositions comprising them | |
| DK0784486T3 (da) | Interleukin-12 som en adjuvans til Paramyxoviridae-vacciner | |
| CN107469075A (zh) | 一种高剂量四价流感疫苗组合物 | |
| Xu et al. | Long-term immunogenicity of an inactivated split-virion 2009 pandemic influenza A H1N1 virus vaccine with or without aluminum adjuvant in mice | |
| Torii et al. | Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients | |
| ES2375436T3 (es) | Administrador intranasal o por inhalación de virosomas. | |
| Markham et al. | Vaccination against Newcastle disease and infectious bronchitis: 1. Preliminary studies in mass vaccination with live virus dust vaccines | |
| Yoshikawa et al. | Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase | |
| Eidson et al. | Vaccination of chickens with a clone-selected Lastoa strain of Newcastle disease virus | |
| RU2546861C1 (ru) | Вакцина против гриппа | |
| CN209858515U (zh) | 一种检测室内甲醛含量的新型设备 | |
| EP0034835A1 (en) | Cholesterol derivatives as intermediary products for the synthesis of immunologic adjuvants | |
| DE69120761T2 (de) | Vakzinale Zusammensetzung gegen infektiöse Pathogene | |
| Kucera et al. | Studies on the antigenicity of an inactivated, aluminum hydroxide adjuvant equine influenza vaccine | |
| Lang Balija et al. | Mumps virus infection of guinea pigs | |
| Woods et al. | A controlled field study using live virus vaccines and an antiserum in a preconditioning program | |
| Rouse et al. | The Response of Ponies to Myxovirus influenzae A-equi 2 I. Serum and Antibody Titres Following Exposure |